Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns.
Nicole Hamilton GoldhaberThomas O'KeefeJessica KangSasha DouglasSarah L BlairPublished in: Annals of surgical oncology (2023)
A trend de-escalation of axillary staging was identified in this study, however the majority of patients meeting the 'Choosing Wisely' criteria are still undergoing SLNBx. No increased risk of nodal positivity was identified among patients with ILC, suggesting that surgeons can continue to choose wisely and limit the use of SLNBx in women over 70 years of age with T1 ILC tumors.
Keyphrases
- end stage renal disease
- lymph node
- newly diagnosed
- chronic kidney disease
- ejection fraction
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- type diabetes
- pregnant women
- clinical trial
- neoadjuvant chemotherapy
- metabolic syndrome
- quality improvement
- skeletal muscle
- insulin resistance
- patient reported
- ultrasound guided
- rectal cancer
- study protocol
- pregnancy outcomes